Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Site 9062
mi
from
Cranford, NJ
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Site 9062
mi
from
Cranford, NJ
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Cheektowaga, NY
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
mi
from
Cheektowaga, NY
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Morehead City, NC
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Toledo, OH
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Bala-Cynwyd, PA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Edegem,
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
mi
from
Edegem,
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Beverly Hills, CA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Bronx, NY
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A Cognitive Behavioral Stress Intervention for Women Who Smoke
Status: Enrolling
Updated:  3/13/2018
Institute for Health, Health Care Policy and Aging Research
mi
from
New Brunswick, NJ
A Cognitive Behavioral Stress Intervention for Women Who Smoke
Status: Enrolling
Updated: 3/13/2018
Institute for Health, Health Care Policy and Aging Research
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Motivational Interviewing to Prevent Suicide in High Risk Veterans
Motivational Interviewing to Prevent Suicide in High Risk Veterans
Status: Enrolling
Updated:  3/14/2018
Syracuse VA Medical Center, Syracuse, NY
mi
from
Syracuse, NY
Motivational Interviewing to Prevent Suicide in High Risk Veterans
Motivational Interviewing to Prevent Suicide in High Risk Veterans
Status: Enrolling
Updated: 3/14/2018
Syracuse VA Medical Center, Syracuse, NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
Healthy Motivations for Moms-to-be Study
Healthy Motivations for Moms-to-be Study
Status: Enrolling
Updated:  3/14/2018
University of South Carolina
mi
from
Columbia, SC
Healthy Motivations for Moms-to-be Study
Healthy Motivations for Moms-to-be Study
Status: Enrolling
Updated: 3/14/2018
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study
Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study
Status: Enrolling
Updated:  3/15/2018
UCSD Medical Center
mi
from
San Diego, CA
Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study
Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study
Status: Enrolling
Updated: 3/15/2018
UCSD Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse
The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse
Status: Enrolling
Updated:  3/15/2018
Geisel School of Medicine at Dartmouth
mi
from
Lebanon, NH
The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse
The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse
Status: Enrolling
Updated: 3/15/2018
Geisel School of Medicine at Dartmouth
mi
from
Lebanon, NH
Click here to add this to my saved trials
Types of Resistant Starch and Their Effect on Appetite
Understanding Resistant Starch on Satiety in Premenopausal Women
Status: Enrolling
Updated:  3/15/2018
Clinical Nutrition Research Center
mi
from
Chicago, IL
Types of Resistant Starch and Their Effect on Appetite
Understanding Resistant Starch on Satiety in Premenopausal Women
Status: Enrolling
Updated: 3/15/2018
Clinical Nutrition Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Status: Enrolling
Updated:  3/15/2018
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Status: Enrolling
Updated: 3/15/2018
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Status: Enrolling
Updated:  3/15/2018
North Shore Hospital
mi
from
Manhasset, NY
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Status: Enrolling
Updated: 3/15/2018
North Shore Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Effects of Adrenal and Gonadal Hormone Replacement in Young Women With Anorexia Nervosa
Status: Enrolling
Updated:  3/15/2018
Children's Hospital Boston
mi
from
Boston, MA
Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Effects of Adrenal and Gonadal Hormone Replacement in Young Women With Anorexia Nervosa
Status: Enrolling
Updated: 3/15/2018
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Allopurinol Add-on Treatment for Refractory Mania
A Double-Blind, Placebo Controlled Augmentation Study With Allopurinol for Treatment Resistant Mania
Status: Enrolling
Updated:  3/16/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Allopurinol Add-on Treatment for Refractory Mania
A Double-Blind, Placebo Controlled Augmentation Study With Allopurinol for Treatment Resistant Mania
Status: Enrolling
Updated: 3/16/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Assessing Neurocognitive Effects of Gluten Exposure
An Assessment of Neurocognitive Symptoms After Gluten Exposure in Adult Patients With Celiac Disease - a Pilot Study
Status: Enrolling
Updated:  3/16/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Assessing Neurocognitive Effects of Gluten Exposure
An Assessment of Neurocognitive Symptoms After Gluten Exposure in Adult Patients With Celiac Disease - a Pilot Study
Status: Enrolling
Updated: 3/16/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Cognitive Retraining and Brain Stimulation for Alcohol Use
Modifying Alcohol Approach Motivations With tDCS and Cognitive Retraining
Status: Enrolling
Updated:  3/16/2018
The Mind Research Network and University of New Mexico Center on Alcoholism, Substance Abuse and Addiction
mi
from
Albuquerque, NM
Cognitive Retraining and Brain Stimulation for Alcohol Use
Modifying Alcohol Approach Motivations With tDCS and Cognitive Retraining
Status: Enrolling
Updated: 3/16/2018
The Mind Research Network and University of New Mexico Center on Alcoholism, Substance Abuse and Addiction
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
Status: Enrolling
Updated:  3/16/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
Status: Enrolling
Updated: 3/16/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Adaptive Care in the Perioperative Setting
Adaptive Care in the Perioperative Setting: An Observational Study
Status: Enrolling
Updated:  3/19/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Adaptive Care in the Perioperative Setting
Adaptive Care in the Perioperative Setting: An Observational Study
Status: Enrolling
Updated: 3/19/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability
Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents (An Open Pilot Study in Autism Spectrum Disorder)
Status: Enrolling
Updated:  3/19/2018
Yale Child Study Center
mi
from
New Haven, CT
Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability
Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents (An Open Pilot Study in Autism Spectrum Disorder)
Status: Enrolling
Updated: 3/19/2018
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
The Effects of Emotional Exposure on State Anxiety
The Effects of Yoga and Quiet Rest on Subjective Levels of Anxiety and Physiological Correlates: A 2-way Randomized Crossover Design
Status: Enrolling
Updated:  3/19/2018
Texas Tech University
mi
from
Lubbock, TX
The Effects of Emotional Exposure on State Anxiety
The Effects of Yoga and Quiet Rest on Subjective Levels of Anxiety and Physiological Correlates: A 2-way Randomized Crossover Design
Status: Enrolling
Updated: 3/19/2018
Texas Tech University
mi
from
Lubbock, TX
Click here to add this to my saved trials
Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study
Remote Administration Of Cognitive Training Tasks In Rural Veterans With PTSD And Comorbid Mild TBI: A Feasibility Study
Status: Enrolling
Updated:  3/20/2018
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study
Remote Administration Of Cognitive Training Tasks In Rural Veterans With PTSD And Comorbid Mild TBI: A Feasibility Study
Status: Enrolling
Updated: 3/20/2018
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Status: Enrolling
Updated:  3/20/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil
Status: Enrolling
Updated: 3/20/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated:  3/20/2018
Mayo Clinic Florida
mi
from
Jacksonville, FL
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated: 3/20/2018
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated:  3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated: 3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Suicide Safety Planning Group Treatment: "Project Life Force"
Suicide Safety Planning Group Treatment - "Project Life Force"
Status: Enrolling
Updated:  3/20/2018
James J. Peters VA Medical Center, Bronx, NY
mi
from
Bronx, NY
Suicide Safety Planning Group Treatment: "Project Life Force"
Suicide Safety Planning Group Treatment - "Project Life Force"
Status: Enrolling
Updated: 3/20/2018
James J. Peters VA Medical Center, Bronx, NY
mi
from
Bronx, NY
Click here to add this to my saved trials
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
A Double-Blind Placebo-Controlled Study of Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults With Bipolar Disorder, Major Depressive Disorder, Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  3/21/2018
University of Cincinnati
mi
from
Cincinnati, OH
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
A Double-Blind Placebo-Controlled Study of Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults With Bipolar Disorder, Major Depressive Disorder, Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 3/21/2018
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated:  3/21/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated: 3/21/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated:  3/21/2018
Michigan State University / Cherry Street Health Services
mi
from
Grand Rapids, MI
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated: 3/21/2018
Michigan State University / Cherry Street Health Services
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated:  3/21/2018
Dartmouth Medical School
mi
from
Lebanon, NH
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated: 3/21/2018
Dartmouth Medical School
mi
from
Lebanon, NH
Click here to add this to my saved trials
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated:  3/21/2018
University of South Carolina School of Medicine
mi
from
Columbia, SC
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Alcoholism and Schizophrenia: A Translational Approach to Treatment
Status: Enrolling
Updated: 3/21/2018
University of South Carolina School of Medicine
mi
from
Columbia, SC
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
University of Miami
mi
from
Miami, FL
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
Michigan State University / Cherry Street Health Services
mi
from
Grand Rapids, MI
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
Michigan State University / Cherry Street Health Services
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
University of North Carolina/UNC Center for Excellence in Community Mental Health
mi
from
Raleigh, NC
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
University of North Carolina/UNC Center for Excellence in Community Mental Health
mi
from
Raleigh, NC
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
University of South Carolina
mi
from
Columbia, SC
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
Rutland Regional Medical Center
mi
from
Rutland, VT
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
Rutland Regional Medical Center
mi
from
Rutland, VT
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
Unversity of Massachusetts Medical School
mi
from
Worcester, MA
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
Unversity of Massachusetts Medical School
mi
from
Worcester, MA
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
CNS Network
mi
from
Garden Grove, CA
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
CNS Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated:  3/21/2018
Pacific Research Partners, LLC
mi
from
Oakland, CA
Clozapine for Cannabis Use in Schizophrenia
Clozapine for Cannabis Use Disorder in Schizophrenia
Status: Enrolling
Updated: 3/21/2018
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Hazelrig-Salter Radiation Oncology Center
mi
from
Birmingham, AL
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Hazelrig-Salter Radiation Oncology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
JMH Mental Health Center, University of Miami
mi
from
Miami, FL
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
JMH Mental Health Center, University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
School of Pharmacy, Univ. of Missouri Kansas City
mi
from
Kansas City, MO
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
School of Pharmacy, Univ. of Missouri Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated:  3/21/2018
West Central Behavioral Health
mi
from
Lebanon, NH
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
Status: Enrolling
Updated: 3/21/2018
West Central Behavioral Health
mi
from
Lebanon, NH
Click here to add this to my saved trials